Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

Search

Top

Georgia Tech Research Corp Atlanta GA 30332 USA

UEI: SLED_CEB1B9199CC10AE0

Georgia Tech Research Corp Atlanta GA 30332 USA is a federal contractor, registered under UEI SLED_CEB1B9199CC10AE0. It has been awarded $202,527,230 across 1 federal contract. Primary work spans Research and Development in Biotechnology (except Nanobiotechnology). Top awarding agencies include FDA Office Of Acq Grant Svcs.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_CEB1B9199CC10AE0

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

FDA Office Of Acq Grant Svcs$202.5M100%

Awards by NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)$202.5M100%

Awards by Agency Over Time

Awards by Place of Performance

Compete with Georgia Tech Research Corp Atlanta GA 30332 USA

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for Georgia Tech Research Corp Atlanta GA 30332 USA

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Join 650+ contractors already using CLEATUS

Open opportunities in Georgia Tech Research Corp Atlanta GA 30332 USA's top NAICS codes and agencies

Functional Characterization and Assay Laboratory ServicesThis subcontract, titled Functional Characterization and Assay Laboratory Services, supports FDA CDER projects through the functional characterization of human hindbrain organoids. The scope of work involves conducting drug-response studies and 3D Microelectrode Array testing to evaluate compound responses, all performed within a DEA-licensed controlled-substance laboratory. The contractor is responsible for providing comprehensive data analysis reports, study reports, and the return of samples. Managed by the Department of Health and Human Services under the FDA Office of Acq Grant Svcs, the project falls under NAICS code 541380. The solicitation was posted on September 11, 2026, with a response deadline of September 17, 2026.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Human Hindbrain Organoid and Culture Material SupplierThis subcontract, managed by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, involves the supply of human hindbrain organoids and specialized cell culture materials. The supplier is responsible for producing and delivering these biological materials and associated media through twelve scheduled shipments to support functional assay projects for prime contractors. The scope of work includes the comprehensive management of shipping and transportation to ensure materials reach the designated performance site. This procurement falls under NAICS code 325211 and was posted on September 11, 2026, with a response deadline of September 17, 2026.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

Solicitation # 75A50126R00001_RFP_NPIVS_27

The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the Vaccine Medical Countermeasures (MCMs) for Pandemic Influenza Preparedness and Response Program. The primary objective is to maintain a permanent readiness posture and a commercially sustainable warm-base production capacity for the rapid manufacture of vaccines, antigens, and adjuvants during public health emergencies. Contractors are required to produce these countermeasures against influenza and other viruses with pandemic potential, generate and submit all necessary analytical, nonclinical, clinical, and chemistry, manufacturing, and controls data to the FDA, and support rapid regulatory decisions. To be eligible, offerors must hold a U.S. influenza vaccine license or have developed an influenza vaccine as evidenced by a Biologics License Application submission. The contract is structured as an IDIQ with a five-year base period and a potential five-year option period, totaling a possible 120-month ordering period. Award decisions will be based on the Highest Technically Rated Offerors with a Fair and Reasonable Price methodology, with a significant emphasis on capabilities. Key requirements include strict adherence to CGMP guidelines, the implementation of comprehensive business and supply continuity plans, and the submission of surge manufacturing and supply chain readiness assessments. Deliverables include the preparation of candidate vaccine viruses and the management of complex logistics, including temperature-controlled shipping and specific packaging standards. Payment is processed quarterly via the Department of Treasury Invoice Processing Platform.

Barda - Aspr / Daappo / Barda Dcma

POSTED

DEADLINE

Industry Day: DARPA Documentation & Decision Support Sprint (D2)

Solicitation # DARPA-SN-26-118

The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) has issued Special Notice DARPA-SN-26-118 to announce a virtual Industry Day on September 22, 2026, for the Documentation and Decision Support Sprint (D2). This initiative aims to advance combat medicine by developing autonomous solutions that use passive sensor data, such as audio, video, and accelerometry, to assist untrained individuals in delivering tactical combat casualty care during the first 20 minutes of treatment. The project is divided into two primary lanes: Lane 1 focuses on the autonomous population of digital DD Form 1380 TCCC Cards, and Lane 2 focuses on providing real-time clinical decision support for non-medics based on Committee on Tactical Combat Casualty Care and Joint Trauma System Clinical Practice Guidelines. This announcement is an informational notice and not a formal solicitation for proposals or abstracts. Interested U.S. entities and citizens must register for the Industry Day by September 20, 2026, at 5:00 PM ET, with attendance limited to the first 1,000 registrants. While no formal proposals are being accepted, prospective competitors may submit one-page teaming profiles to D2Sprint@darpa.mil by September 22, 2026, to facilitate partnership arrangements. The D2 effort will be conducted at the unclassified level and will utilize targeted prize incentives to catalyze technological advancements. Technical and administrative inquiries are directed to Dr. Jeremy Pamplin and the D2Sprint email address.

Defense Advanced Research Projects Agcy

POSTED

DEADLINE

DARPA Surgical Competition (DSC) Industry Day

Solicitation # DARPA-SN-26-125

The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) is hosting an Industry Day for the DARPA Surgical Competition (DSC) on September 22, 2026, from 9:00 AM to 12:30 PM ET. This hybrid event, held in Arlington, Virginia, and virtually, aims to introduce a competition focused on developing a minimum viable product for scalable, autonomous robotic trauma surgery systems. The competition is designed to establish the state of the art for open robotic trauma surgery and identify technologies for autonomous surgical assistance. Performance will be evaluated through three primary lanes: Component Gates, which assess system safety and autonomy across medical knowledge, physical capability, and rapid learning; Surgical Collaboration, which tests the platform's ability to work alongside a human surgeon; and Surgical Independence, which evaluates the system's ability to plan and execute end-to-end trauma procedures without assistance. While this special notice is not a formal request for proposals, interested parties are invited to participate by registering and optionally submitting materials by September 18, 2026. These materials include a single-slide landscape PDF for a three-minute lightning talk and a teaming profile detailing technical competencies and collaboration goals. All submissions must contain only unclassified, non-proprietary information. Technical and administrative inquiries are managed by Program Manager Jeremy Pamplin via the SurgicalCompetition@darpa.mil email address.

Defense Advanced Research Projects Agcy

POSTED

DEADLINE

Human Hindbrain Organoid Functional Assay Services.

Solicitation # RFQ_CDR-2026-135968

The U.S. Food and Drug Administration's Center for Drug Evaluation and Research is seeking a firm-fixed-price purchase order for human induced pluripotent stem cell-derived hindbrain organoid functional assay services. The contract involves the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to evaluate electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. This is a commercial service acquisition under FAR Part 12, intended as a sole-source award to OrganoTherapeutics SARL based on market research identifying them as the only source capable of meeting the full requirement. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Analytical Instrument Calibration and Technical Support

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

FFF System Integration and Online Detection Implementation

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Quasi-Elastic Light Scattering (QELS) / Dynamic Light Scattering (DLS) Detector Supplier

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

On-site Analyst Training Services

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

LC/IC System Installation and Implementation Services

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Supply of Dionex ICS-6000 HPIC System

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Supply of Vanquish Neo LC System

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Senior Epidemiologist / Mathematical Statistician

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Senior Physician Subject Matter Expert (SME) - Pharmacovigilance

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Specialized Equipment Shipping (FOB Destination)

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

in about 23 hours

Technical Validation and Operator Training Services

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

in about 23 hours

Walk-In Laboratory Cooler Manufacturer/Supplier

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

in about 23 hours